3 Sixty Reports Record Revenue in the Third Quarter of 2019, Breakeven Adjusted EBITDA, and Significant Sequential Improvement in Net Cash Flow Cannabis Investing News
Cardiol Therapeutics Announces Clinical Steering Committee for Phase 2 International Trial in Acute Myocarditis Using CardiolRx(TM) 100 Cannabis Investing News
Syntholene Energy Announces DTC Eligibility and Provides Update Regarding Investor Relations Activity